Grandpa’s Mill' is an ambitious & evocative work, blending Appalachian folk, country and flashes of alt-rock into a deeply ...
Affinia Therapeutics has received the US Food and Drug Administration (FDA) fast track designation (FTD) for AFTX-201, a ...
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...
Top Line Results Expected in the Fourth Quarter of 2026 - WAYNE, Pa., March 18, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics ...
T Cells Gain Phagocytic Function via Specific Antigen RecognitionThe research team engineered CD8+ Jurkat T cells to express SVAR16 ...
The World Federation of Societies of Biological Psychiatry (WFSBP) has reached consensus on candidate biomarkers for anorexia ...
Investigating microplastics in agriculture reveals their effects on soil microbes and viruses, crucial for developing ...
Targeted modulation of certain intracellular signaling proteins could represent an exciting new approach to drug development.
The GPR133 receptor is expressed by osteoblasts, the cells that make bone. The study suggests that this receptor helps those cells sense two kinds of input: mechanical strain and signals relayed by ...
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results